Literature DB >> 12184547

Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study.

Magnus Sundbom1, Hans Hedenström, Sven Gustavsson.   

Abstract

In this exploratory study, we examined the occurrence of duodenogastric bile reflux to the excluded stomach after Roux-en-Y gastric bypass, a standard surgical therapy for morbid obesity. We studied 22 unselected patients (median age 44, 20 females) 18 months postoperatively. BMI at surgery and cholescintigraphy was 45 and 29 kg/m2, respectively. Mebrofenin labeled with 200 MBq 99mT was injected intravenously and the fate of radioactivity followed for 90 min. Bile flow was enhanced with cholecystokinin. We found scintigraphic evidence of duodenogastric bile reflux in 36% of the patients. The tracer remained in the excluded stomach throughout the study period. In conclusion, our investigation indicates that in more than one third of the patients undergoing gastric bypass, the gastric mucosa in the excluded stomach is exposed to the potential deleterious effects of bile.

Entities:  

Mesh:

Year:  2002        PMID: 12184547     DOI: 10.1023/a:1016429603337

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Enterogastric reflux after various types of antiulcer gastric surgery: quantitation by 99mTc-HIDA scintigraphy.

Authors:  E Xynos; J S Vassilakis; A Fountos; G Pechlivanides; N Karkavitsas
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

2.  Gastric bypass operation for obesity.

Authors:  M A Fobi; H Lee; R Holness; D Cabinda
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

3.  Resectional gastric bypass is a new alternative in morbid obesity.

Authors:  T K Curry; P L Carter; C A Porter; D M Watts
Journal:  Am J Surg       Date:  1998-05       Impact factor: 2.565

4.  Gallbladder function and fasting enterogastric bile reflux.

Authors:  N S Kennedy; F C Campbell; P T Cullen; D G Sutton; B W Millar; A Cuschieri
Journal:  Nucl Med Commun       Date:  1989-03       Impact factor: 1.690

5.  Pertechnetate and the Stomach--a continuing controversy.

Authors:  J G Williams
Journal:  J Nucl Med       Date:  1983-07       Impact factor: 10.057

6.  Scintigraphic assessment of biliary reflux into the residual stomach after subtotal gastrectomy and gastrojejunostomy.

Authors:  S Gustavsson; L K Enander; B Jung; M Krog
Journal:  Acta Radiol Diagn (Stockh)       Date:  1980

7.  Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up.

Authors:  A C Wittgrove; G W Clark
Journal:  Obes Surg       Date:  2000-06       Impact factor: 4.129

8.  Cholecystectomy as a risk factor for gastric cancer. A cohort study.

Authors:  S Gustavsson; H O Adami; O Meirik; O Nyrén; U B Krusemo
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

9.  New scintigraphic method for the quantitative measurement of enterogastric reflux.

Authors:  J B Svedberg; P A Karlqvist; E Lindström; R Sjödahl
Journal:  Scand J Gastroenterol       Date:  1984-10       Impact factor: 2.423

10.  Acute gastric mucosal ulcerogenesis is dependent on the concentration of bile salt.

Authors:  W P Ritchie; E W Shearburn
Journal:  Surgery       Date:  1976-07       Impact factor: 3.982

View more
  13 in total

1.  Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation.

Authors:  Chao Zhang; Zhan-Kui Liu; Pei-Wu Yu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  MALT Lymphoma of the Gastric Remnant After Roux-en-Y Gastric Bypass.

Authors:  Ahmed Jawad; Allan H Bar; Demetri Merianos; Jing Zhou
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Epithelial cell turnover is increased in the excluded stomach mucosa after Roux-en-Y gastric bypass for morbid obesity.

Authors:  Adriana V Safatle-Ribeiro; Pedro A Petersen; Dilson S Pereira Filho; Carlos E P Corbett; Joel Faintuch; Robson Ishida; Paulo Sakai; Ivan Cecconello; Ulysses Ribeiro
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

4.  Bile Reflux Scintigraphy After Mini-Gastric Bypass.

Authors:  Tuure Saarinen; Jari Räsänen; Jarmo Salo; Antti Loimaala; Miia Pitkonen; Marja Leivonen; Anne Juuti
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

5.  HIDA and Seek: Challenges of Scintigraphy to Diagnose Bile Reflux Post-Bariatric Surgery.

Authors:  Thomas A Eldredge; Madison Bills; Jennifer C Myers; Dylan Bartholomeusz; George K Kiroff; Jonathan Shenfine
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

6.  Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity.

Authors:  Attila Csendes; Ana Maria Burgos; Gladys Smok; Marcelo Beltran
Journal:  Obes Surg       Date:  2007-01       Impact factor: 4.129

7.  Laparoscopic resectional gastric bypass in patients with morbid obesity: experience on 112 consecutive patients.

Authors:  Italo Braghetto; Attila Csendes; Owen Korn; Luis Gutierrez; Luis Brunet; Enrique Lanzarini; Maher Mushle; Héctor Valladares; Jorge Rojas
Journal:  J Gastrointest Surg       Date:  2011-01       Impact factor: 3.452

8.  Laparoscopic resectional gastric bypass: initial experience in morbidly obese Korean patients.

Authors:  Ji Yeon Park; Yong Jin Kim
Journal:  Surg Today       Date:  2014-12-18       Impact factor: 2.549

9.  What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity.

Authors:  Adriana Vaz Safatle-Ribeiro; Rogério Kuga; Kiyoshi Iriya; Ulysses Ribeiro; Joel Faintuch; Robson K Ishida; Carlos Eduardo P Corbett; Arthur Belarmino Garrido; Shinichi Ishioka; Paulo Sakai
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

10.  Laparoscopic subtotal gastrectomy in morbid obese patients: a valid option to laparoscopic gastric bypass in particular circumstances (prospective study).

Authors:  Italo Braghetto; Gustavo Martinez; Owen Korn; Marcelo Zamorano; Enrique Lanzarini; Enrique Narbona
Journal:  Surg Today       Date:  2018-02-15       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.